Canaccord Genuity Group Issues Positive Forecast for Anpario (LON:ANP) Stock Price

Anpario (LON:ANP) had its price objective lifted by Canaccord Genuity Group from GBX 380 ($4.64) to GBX 500 ($6.10) in a report released on Tuesday, Marketbeat.com reports. They currently have a buy rating on the stock.

Separately, Canaccord Genuity Group lifted their target price on shares of Anpario from GBX 340 ($4.15) to GBX 370 ($4.52) and gave the stock a “buy” rating in a research report on Wednesday, September 18th.

Anpario Price Performance

Anpario stock opened at GBX 441.85 ($5.39) on Tuesday. The company has a market capitalization of £74.72 million, a PE ratio of 2,454.72 and a beta of 0.58. The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.21. The stock has a 50-day moving average price of GBX 359.86 and a two-hundred day moving average price of GBX 321.21. Anpario has a 12 month low of GBX 220 ($2.69) and a 12 month high of GBX 454.90 ($5.55).

Insiders Place Their Bets

In other Anpario news, insider Karen Prior sold 14,000 shares of the stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of GBX 380 ($4.64), for a total transaction of £53,200 ($64,949.33). Company insiders own 30.51% of the company’s stock.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.